During the last session, Aehr Test Systems (NASDAQ:AEHR)’s traded shares were 0.88 million, with the beta value of the company hitting 1.94. At the end of the trading day, the stock’s price was $8.85, reflecting an intraday gain of 0.23% or $0.02. The 52-week high for the AEHR share is $21.44, that puts it down -142.26 from that peak though still a striking 3.16% gain since the share price plummeted to a 52-week low of $8.57. The company’s market capitalization is $262.95M, and the average trade volume was 1.31 million shares over the past three months.
Aehr Test Systems (AEHR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. AEHR has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.04.
Aehr Test Systems (NASDAQ:AEHR) trade information
Aehr Test Systems (AEHR) registered a 0.23% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.23% in intraday trading to $8.85, hitting a weekly high. The stock’s 5-day price performance is -8.20%, and it has moved by -19.98% in 30 days. Based on these gigs, the overall price performance for the year is -46.62%.
The consensus price target of analysts on Wall Street is $25, which implies an increase of 64.6% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $25 and $25 respectively. As a result, AEHR is trading at a discount of -182.49% off the target high and -182.49% off the low.
Aehr Test Systems (AEHR) estimates and forecasts
In the rating firms’ projections, revenue will increase 3.76% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 17.76M as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 24.37M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 7.56M and 16.6M respectively. In this case, analysts expect current quarter sales to grow by 134.82% and then jump by 46.82% in the coming quarter.
While earnings are projected to return -67.31% in 2025, the next five years will return -9.98% per annum.
AEHR Dividends
Aehr Test Systems is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 1.9 million shares, is of BLACKROCK INC.’s that is approximately 6.6057% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $21.26 million.
Also, the Mutual Funds coming in first place with the largest holdings of Aehr Test Systems (AEHR) shares are Vanguard Total Stock Market Index Fund and Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 860.41 shares. This amounts to just over 2.90 percent of the company’s overall shares, with a $7.61 million market value. The same data shows that the other fund manager holds slightly less at 743.04, or about 2.50% of the stock, which is worth about $6.58 million.
